PlainVisa
2026 data Public-data reference Official source

Karyopharm Therapeutics Inc.

A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.

DOL LCA filings
31
DOL-certified
100%
Median offered wage
$140,300

Newton, MA NAICS: 541714

How many H-1B LCA filings list Karyopharm Therapeutics Inc.?

U.S. Department of Labor's OFLC discloses 31 Labor Condition Application filings naming Karyopharm Therapeutics Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs

How many H-1B petitions has USCIS approved for Karyopharm Therapeutics Inc.?

Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 56 H-1B petitions naming Karyopharm Therapeutics Inc. through FY2024, and approved the large majority of them: 96.4% approved (54 approvals, 2 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.

The verdict

Karyopharm Therapeutics Inc. is listed in 31 DOL LCA filings, more filings than 94% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $140,300. This is not a USCIS approval, hiring, or sponsorship ranking.

31
DOL LCA filings, FY2023–FY2026
100%
DOL-certified
$140,300
median offered wage
Top 6%
of employer filers by volume

According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Newton, MA.

Saved on this device only, no account, no email. Open saved list Follow this profile's data updates Updates when the published DOL data vintage changes; this is a feed, not an alert service.

Karyopharm Therapeutics Inc. vs all U.S. employer filers by LCA volume

Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)

31 7990th of 122824 higher than 114,834 of 122,824 employer filers

Employer filers, banded by disclosed H-1B LCA filing count

Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source U.S. Department of Labor OFLC · FY2023–FY2026

LCA filing shape · Karyopharm Therapeutics Inc.

Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.

Offered-wage span on file: $96,616$190,215 .

Title concentration

  • Sr Clinical Data Manager 4 · 12.9% · $123,179
  • Senior Manager, Regulatory Operations 4 · 12.9% · $177,350
  • Sr Scientist, Analytical Chemistry 3 · 9.7% · $150,241
  • Senior Clinical Data Manager 3 · 9.7% · $125,719
  • Sr. Clinical Trial Manager 2 · 6.5% · $160,000

Worksite counties

  • NEWTON CITY, MA 15 · 62.5%
  • FAIRFAX, VA 3 · 12.5%
  • BERGEN, NJ 2 · 8.3%
  • PRINCE WILLIAM, VA 1 · 4.2%
  • WASHINGTON, AR 1 · 4.2%

DOL LCA release change

What changed between the two LCA fiscal years

FY2024 -> FY2025
  • Karyopharm Therapeutics Inc.'s disclosed H-1B LCA filing count rose from 2 in FY2024 to 8 in FY2025 (+300%).

Arithmetic differences between stored DOL OFLC Labor Condition Application disclosure fiscal years for this employer identity - not a headcount, hire forecast, or cause claim. Role mix can shift between years even when the filing total is flat. Totals group name variants that share the same identity key.

National filing changes Two-year CSV

Above-prevailing wage posture

On 31 LCAs with comparable offered vs prevailing wages, Karyopharm Therapeutics Inc. averages about 13.9% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (41.9% of LCA filings).

Cooling filing trend

Completed-year LCA counts fell from 16 in FY2023 to 8 in FY2025 (≈50% of the earlier year). Cumulative volume still 31.

Certification Rate

100%

Very high DOL cert

Avg. Salary

$140,300

Above portal avg

Total Workers

31

Small worker count

Wondering how long it takes USCIS to process an H-1B petition for this employer? See current I-129 processing times →

Salary Analysis

Compensation range for H-1B positions at Karyopharm Therapeutics Inc.

Minimum
$96,616
Maximum
$190,215
Average Salary
$140,300

Wage vs. DOL Minimum

+13.9%

At/above DOL floor

national avg +17.8%

Typical DOL Wage Level

Fully Competent (Level IV)

41.9% of LCA filings

Full-Time Positions

100%

Primary Worksite County

NEWTON CITY, MA

48.4% of LCA filings

Top Occupations

Most frequently listed job titles at Karyopharm Therapeutics Inc.

Job Title LCA filings Avg. Salary
Sr Clinical Data Manager 4 $123,179
Senior Manager, Regulatory Operations 4 $177,350
Sr Scientist, Analytical Chemistry 3 $150,241
Senior Clinical Data Manager 3 $125,719
Sr. Clinical Trial Manager 2 $160,000
Pharmacovigilance Specialist 2 $110,000
Manager, Regulatory Operations 2 $134,966
Manager, Regulatory Affairs 2 $120,000
Associate Director, IST Operations 2 $124,747
Sr Scientist Bioanalytical 1 $145,000
Senior Statistical Programmer 1 1 $123,966
SENIOR BIOSTATISTICIAN 1 $187,044
Manager Regulatory Operations 1 $109,745
GCP Documentation Specialist 1 $96,616
Associate Director, XPOVIO U.S. Multiple Myeloma Marketing 1 $169,000

Nationwide peers near Karyopharm Therapeutics Inc.'s 31-LCA band

Cross-state DOL neighbors for Karyopharm Therapeutics Inc. - LCA filing-count and offered-wage axes, outside MA.

Similar LCA filing volume

Nearest cross-state employer filers by LCA filing count (31 here; floor ≥10 LCA filings).

Similar avg offered wage

Cross-state employer filers with a comparable average listed offered wage ($140,300 here).

Frequently Asked Questions

How many H-1B LCA filings list Karyopharm Therapeutics Inc.?

Karyopharm Therapeutics Inc. is listed in 31 DOL Labor Condition Application filings covering 31 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.

How does Karyopharm Therapeutics Inc.'s LCA filing volume compare to other employer filers?

Among 122,824 employer filers in the DOL disclosure extract, Karyopharm Therapeutics Inc. ranks #7786 by total LCA filing count (31 filings). 114,834 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.

What is the H-1B DOL certification rate for Karyopharm Therapeutics Inc.?

Karyopharm Therapeutics Inc. has a 100% DOL certification rate, with 31 out of 31 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.

What offered wage is listed in LCAs for Karyopharm Therapeutics Inc.?

The average offered wage listed in Karyopharm Therapeutics Inc.'s LCAs is $140,300. Listed wages range from $96,616 to $190,215 and are not verified actual compensation.

What are the most common H-1B job titles at Karyopharm Therapeutics Inc.?

The top job titles in Karyopharm Therapeutics Inc.'s LCA filing records include Sr Clinical Data Manager, Senior Manager, Regulatory Operations, Sr Scientist, Analytical Chemistry. The most common listed title is Sr Clinical Data Manager with 4 LCA filings at an average listed offered wage of $123,179. This does not establish actual job openings, hiring, or approved petitions.

Where is Karyopharm Therapeutics Inc. located?

Karyopharm Therapeutics Inc. is headquartered in Newton, MA. Their H-1B workers are distributed across 6 states, with the most positions in MA, VA, AR.

Is Karyopharm Therapeutics Inc. H-1B dependent?

No, Karyopharm Therapeutics Inc. is not classified as H-1B dependent.

How have Karyopharm Therapeutics Inc.'s listed LCA filings changed over time?

Karyopharm Therapeutics Inc. is listed in 16 LCA filings in FY2023 and 5 in FY2026. The average listed offered wage increased from $133,309 to $174,835. This historical filing series does not predict sponsorship, hiring, or visa outcomes.

Data sourced from U.S. Department of Labor LCA disclosure filings. See our methodology for details.

Disclaimer: Informational only, not professional advice.

Read with Karyopharm Therapeutics Inc.

ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.

What to do with this profile

Use the DOL LCA record for Karyopharm Therapeutics Inc. to compare filing volume and offered wages, not USCIS outcomes.

DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.

Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.